International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.09 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 202 shares changing hands.
International Stem Cell Stock Performance
The business has a fifty day simple moving average of $0.09 and a 200-day simple moving average of $0.09. The firm has a market cap of $907,200.00, a price-to-earnings ratio of -1.89 and a beta of 0.25.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last announced its earnings results on Tuesday, May 14th. The biotechnology company reported ($0.03) EPS for the quarter. The company had revenue of $2.13 million during the quarter.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- Best Aerospace Stocks Investing
- RXO Shares Surge Following New Acquisition Deal
- What Investors Need to Know to Beat the Market
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Calculate Return on Investment (ROI)
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
